229 related articles for article (PubMed ID: 10692750)
1. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
Bandak SI; Bolzon LD; Turnak MR; Johns D; Henle SK; Allen BS
Int J Clin Pract; 1999 Dec; 53(8):578-83. PubMed ID: 10692750
[TBL] [Abstract][Full Text] [Related]
2. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
Aggarwal M; Sinha R; Murali MV; Trihan P; Singhal PK
Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
[TBL] [Abstract][Full Text] [Related]
4. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
Alanis A; Longest KA; Senetar JE; Dere WH
Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
[TBL] [Abstract][Full Text] [Related]
5. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
Sethi S; Breton J; Wynne B
Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
[TBL] [Abstract][Full Text] [Related]
7. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
8. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis.
Grossman RF
Postgrad Med J; 1992; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
10. Oral cefaclor for treatment of bronchitis--a comparative double-blind study versus amoxycillin.
Beumer HM; Veldkamp J
Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):113-7. PubMed ID: 7068283
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of twice-daily amoxycillin/clavulanate in lower respiratory tract infections.
Balgos AA; Rodriguez-Gomez G; Nasnas R; Mahasur AA; Margono BP; Tinoco-Favila JC; Sansores-Martinez RH; Hassan M; Beppo O; Wongsa A; Cukier A; Vargas F
Int J Clin Pract; 1999; 53(5):325-30. PubMed ID: 10695094
[TBL] [Abstract][Full Text] [Related]
14. A randomized, observer-blind trial of amoxycillin/clavulanate versus cefaclor in the treatment of children with acute otitis media. Augmentin 415 Study Group.
Subba Rao SD; Macias MP; Dillman CA; Ramos BD; Kierszenbaum JS; Soliman AE
J Chemother; 1998 Dec; 10(6):460-8. PubMed ID: 9876054
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitis.
Chodosh S
Am J Med; 1993 Mar; 94(3A):131S-135S. PubMed ID: 8452169
[TBL] [Abstract][Full Text] [Related]
17. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
Paster RZ; McAdoo MA; Keyserling CH; Nemeth MA; Tack KJ; Griffin TJ
Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
[TBL] [Abstract][Full Text] [Related]
18. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Ruoff GE
Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
Poachanukoon O; Kitcharoensakkul M
Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
[TBL] [Abstract][Full Text] [Related]
20. A randomised, prospective, single-blind comparison of cefadroxil and amoxycillin in the treatment of acute exacerbations of chronic bronchitis.
Bint AJ; Cefai C; McGhie D; Perera BS
Br J Clin Pract; 1989 Jan; 43(1):19-23. PubMed ID: 2686741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
